Gene editing promises everything from treatments for serious conditions like sickle cell disease to the resurrection of the dodo.
Academic rigor, journalistic flair
Articles on Gene editing
Displaying 1 - 20 of 96 articles
Scientific and public uproar resulted when the Chinese scientist announced the births of the first human babies with heritable edits to their genes. A new documentary reexamines the saga.
The biotech sector uses climate change as an urgent argument for more funding and fewer regulatory hurdles. But the urgency of climate change raises the risk of superficial claims and actions.
As genetic engineering and DNA manipulation tools like CRISPR continue to advance, the distinction between what science ‘could’ and ‘should’ do becomes murkier.
The rapid rate of species declines means we should trial potential solutions before it’s too late.
Rabies, for example, is a naturally occurring ‘zombie’ disease.
Hox genes make sure all your body parts grow in the right place. Understanding how they work can reveal the process of evolution and lead to potential treatments for congenital birth defects.
Field trials of genetically edited crop plants are to be allowed in England under new government proposals.
Catherine Price, sociologist, and Nicola Patron, synthetic plant biologist, discuss the promises, dangers and concerns around gene edited and GM crops.
Three pioneering technologies have forever altered how researchers do their work and promise to revolutionize medicine, from correcting genetic disorders to treating degenerative brain diseases.
The sketchy history of international efforts to control bioweapons suggests that nations will resist cooperative monitoring of gene hacking for medical research.
The achievement didn’t live up to the hype, but it has illuminated new areas of ‘genetic dark matter’.
Using ‘base editing’, researchers have cured progeria in mice. This genetic syndrome causes premature ageing in humans – those with the disease usually don’t live past the age of 13.
Plant scientists hope to avoid a repeat of the GM foods debate from two decades ago.
Jennifer Doudna and Emmanuelle Charpentier have been awarded the Nobel prize in Chemistry for their revolutionary work on ‘gene scissors’ that can edit DNA.
The tools to rewrite the genetic code to improve crops and livestock, or to treat genetic diseases, has revolutionized biology. A CRISPR engineer explains why this technology won the Nobel, and its potential.
Most scientific discoveries these days aren’t easily ascribed to a single researcher. CRISPR is no different – and ongoing patent fights underscore how messy research can be.
Our approach to controversial technologies shouldn’t be guided by scientists alone, nor by peddlers of misinformation on social media. A citizens’ assembly could walk the line between the two.
The immune system is trained to destroy viruses, even when they carry therapeutic cargo as is the case in gene therapy. Now researchers have figured out how to dial down the immune response.
A person dies of opioid overdose once every 13 minutes in the US. A researcher proposes a way using existing technology to remove the opioid target in people to prevent overdoses.
Top contributors
-
Merlin Crossley is a Friend of The Conversation.Deputy Vice-Chancellor Academic Quality and Professor of Molecular Biology, UNSW Sydney
-
Assistant Professor in Biomedical Ethics, National University of Singapore
-
Geneticist and Group Leader, The John Curtin School of Medical Research, Australian National University
-
Associate professor, Queensland University of Technology
-
University Research Professor, Philosophy, Dalhousie University
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Professor of Responsible Innovation, Arizona State University
-
Professor of Chemistry, Connecticut College
-
Doctoral Student in Biochemistry, University of Washington
-
Director of Research and Professor of Pathology, Dalhousie University
-
Vanier Scholar and Ph.D. Candidate in Microbiology and Immunology, Dalhousie University
-
Shah Rising Star Assistant Professor of Chemical Engineering, Herbert Wertheim College of Engineering, UF Health Cancer Center, University of Florida
-
Researcher, Lecturer, Attorney, University of KwaZulu-Natal
-
Professor - Emerging Technologies (Stem Cells) at The University of Melbourne and Group Leader - Stem Cell Ethics & Policy at the Murdoch Children's Research Institute, The University of Melbourne
-
Research Fellow in Biomedical Ethics, The University of Melbourne
